EMA publishes QPPV Update
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In April 2016 the European Medicines Agency (EMA) published the first issue of the quarterly issued "QPPV Update - What´s new in Pharmacovigilance". The "QPPV Update" replaces the "Pharmacovigilance Programme Update" which focused on information systems and services.
The new newsletter contains general information regarding pharmacovigilance and provides Qualified Persons responsible for Pharmacovigilance (QPPVs) and all other people working in pharmacovigilance with an update on EU pharmacovigilance.
The first issue of the "QPPV Update" covers the following topics:
- Pharmacovigilance in the product lifecycle,
- Pharmacovigilance processes,
- Pharmacovigilance guidance,
- Pharmacovigilance IT systems,
- Pharmacovigilance dialogue.
Qualified Persons for Pharmacovigilance (QPPVs) who are registered in the XEVMPD database according to Article 57 of Regulation (EG) No 726/2004 receive this document directly via EudraLink. You can find the Newsletter on the website of the EMA.
Related GMP News
21.10.2026EMA Clarifies ESMP Reporting for Critical Medicine Shortages
20.10.2026EDQM Updates Guidance on CEP Sister File Applications
20.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
14.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
23.09.2026IRIS Portal: EMA expands digital Procedure Management